bridgedesign.com
Oraya IRay® Radiotherapy | Bridge Design Inc
http://bridgedesign.com/portfolio/iray-amd-radiotherapy-interface
Patient setup on the IRay system requires a trained technician to perform many steps ensuring precise alignment for treatment. Bridge worked with Oraya to design a user interface that balances procedural guidance with key treatment feedback, maximizing comprehension and ease of use. By defining key steps and grouping information intuitively, the UI provides a quick and low-stress experience for both technician and patient. Watch the BBC news clip. Working towards a refined user interface.
healthology.racepointglobal.com
The Moment of Truth: The Reality of Vision Loss in the UK in 2015 - Healthology
http://healthology.racepointglobal.com/2015/05/21/moment-truth-reality-vision-loss-uk-2015
The Moment of Truth: The Reality of Vision Loss in the UK in 2015. May 21, 2015. On Tuesday I attended the Royal College of Ophthalmologists. I confess to being fascinated by eye health and the amazing innovations that have taken place in the treatment of eye disease over the last twenty years. I have and continue to run communications programmes and marketing campaigns for a number of companies in this area and the intricacy of the eye and expertise of ophthalmologists never ceases to amaze me. Is both ...
escrseurotimes.org
EuroTimes
http://www.escrseurotimes.org/default.asp
Raquo; Latest News. Raquo; Archived Stories. Raquo; Cover Stories. Raquo; EuroTimes ISSUU. Raquo; About Us. Raquo; Medical Editors. GOODBYE PHACO, HELLO FEMTO: Femto cataract surgery appears to offer greater accuracy and consistency, while reducing or eliminating the need for phaco. Dr Oliver Findl talks with Dr Burkhard Dick about the applications and advantages of this approach. Exciting series of sessions at ESCRS meeting to provide update on glaucoma management. GENE THERAPY AND RETINAL DISEASE.
axon-cro.com
AXON-CRO Welcome
http://www.axon-cro.com/index.htm
Welcome to Axon CRO! Is a privately held company with branches in the Czech and Slovak Republic. Is a service clinical research organization providing a comprehensive range of clinical services to manage Phase I-IV clinical trials to pharmaceutical, biotechnology and device industry processes from initial planning to approval — on time and on budget. Can be accomplished by our team of highly skilled individuals from our office in Prague. Axon CRO, s.r.o. Tel: 420 737268655, 420 737268695.
axon-cro.com
AXON-CRO Trials Management Service
http://www.axon-cro.com/trials.htm
Axon CRO has extensive resources and expertise to design and conduct studies on a regional basis, and prepare and submit regulatory submissions in Central and Eastern Europe. A typical Trials Management Services project may involve the following components:. Project management (incl. reviewing the proposal and budget). Hospital/investigator contract negotiation (lawyer consultancy). Study drugs packaging, blinding, labeling and distribution (GMP). Medical monitoring and drug safety (SAE, ADR processing).
robertpetrarca.co.uk
About -Dr Robert Petrarca
http://robertpetrarca.co.uk/aboutus.html
FRCOphth MD (Res) MBBS MCOptom BSc (Hons). About Mr Robert Petrarca. Jackson TL. ' Radiation Therapy For Wet Age-related Macular Degeneration'. Chapter 20 In: Alfaro DV, Editor. Age-related Macula Degeneration: A Comprehensive Textbook. 2nd edition.Published by Philadelphia: Lippincott Williams and Wilkins; 2014. Ophthalmology Handbook for Junior Doctors'. Electronic-book published on East Sussex Healthcare NHS Trust Intranet, 2012. Peer Review Publications and Abstracts -. Van Lancker L, Petrarca R.
art-media.eu
ART.media: Referenzen
http://www.art-media.eu/ueber-uns/referenzen
Im Bereich Gesundheit and Medizin. Zu Medien, Ärzten and Industrie.
synergylsp.com
Portfolio
http://www.synergylsp.com/port.html
Aptus Endosystems, Inc., Sunnyvale, CA. Inspire Medical Systems, Inc., Minneapolis, MN. Inspire Medical Systems, Inc., based in Minneapolis, Minnesota, was created to be the world's leading provider of innovative and cost-effective implantable therapeutic devices for the treatment of Obstructive Sleep Apnea. The focus for the company is developing and commercially releasing the Inspire system for the treatment of Obstructive Sleep Apnea (OSA). IRhythm Technologies, Inc., San Francisco, CA.